Logo image of NPCT

NUVEEN CORE PLUS IMPACT (NPCT) Stock Price, Quote, News and Overview

NYSE:NPCT - New York Stock Exchange, Inc. - US67080D1037 - Currency: USD

10.68  -0.06 (-0.56%)

After market: 10.68 0 (0%)

Fundamental Rating

2

Overall NPCT gets a fundamental rating of 2 out of 10. We evaluated NPCT against 0 industry peers in the Unkown industry. Both the profitability and financial health of NPCT have multiple concerns. NPCT is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

NPCT had positive earnings in the past year.
NPCT had a positive operating cash flow in the past year.
NPCT Yearly Net Income VS EBIT VS OCF VS FCFNPCT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 50M -50M 100M -100M -150M

1.2 Ratios

Industry RankSector Rank
ROA 5.21%
ROE 8.16%
ROIC 2.07%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NPCT Yearly ROA, ROE, ROICNPCT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 -10 -20 -30 -40 -50

1.3 Margins

In the last couple of years the Profit Margin of NPCT has grown nicely.
NPCT's Operating Margin has declined in the last couple of years.
NPCT's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 45.29%
PM (TTM) 90.32%
GM 45.42%
OM growth 3Y-10.38%
OM growth 5YN/A
PM growth 3Y5.67%
PM growth 5YN/A
GM growth 3Y-8.8%
GM growth 5YN/A
NPCT Yearly Profit, Operating, Gross MarginsNPCT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 -200 -400

More info and screens

1

2. Health

2.1 Basic Checks

NPCT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
NPCT Yearly Shares OutstandingNPCT Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 5M 10M 15M 20M 25M
NPCT Yearly Total Debt VS Total AssetsNPCT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 200M 400M 600M 800M

2.2 Solvency

NPCT has an Altman-Z score of 0.50. This is a bad value and indicates that NPCT is not financially healthy and even has some risk of bankruptcy.
NPCT has a debt to FCF ratio of 4.17. This is a neutral value as NPCT would need 4.17 years to pay back of all of its debts.
A Debt/Equity ratio of 0.56 indicates that NPCT is somewhat dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.56
Debt/FCF 4.17
Altman-Z 0.5
ROIC/WACCN/A
WACCN/A
NPCT Yearly LT Debt VS Equity VS FCFNPCT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.3 Liquidity

NPCT has a Current Ratio of 0.01. This is a bad value and indicates that NPCT is not financially healthy enough and could expect problems in meeting its short term obligations.
NPCT has a Quick Ratio of 0.01. This is a bad value and indicates that NPCT is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.01
Quick Ratio 0.01
NPCT Yearly Current Assets VS Current LiabilitesNPCT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 50M 100M

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 35.21% over the past year.
NPCT shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 36.20% yearly.
NPCT shows a small growth in Revenue. In the last year, the Revenue has grown by 4.36%.
The Revenue has been growing by 29.57% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)35.21%
EPS 3Y36.2%
EPS 5YN/A
EPS Q2Q%-23.73%
Revenue 1Y (TTM)4.36%
Revenue growth 3Y29.57%
Revenue growth 5YN/A
Sales Q2Q%-3.82%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NPCT Yearly Revenue VS EstimatesNPCT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 10M 20M 30M

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 11.13, the valuation of NPCT can be described as reasonable.
The average S&P500 Price/Earnings ratio is at 26.52. NPCT is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 11.13
Fwd PE N/A
NPCT Price Earnings VS Forward Price EarningsNPCT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF 6.73
EV/EBITDA N/A
NPCT Per share dataNPCT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

3

5. Dividend

5.1 Amount

NPCT has a Yearly Dividend Yield of 12.27%, which is a nice return.
NPCT's Dividend Yield is rather good when compared to the S&P500 average which is at 2.38.
Industry RankSector Rank
Dividend Yield 12.27%

5.2 History

NPCT has been paying a dividend for over 5 years, so it has already some track record.
The dividend of NPCT decreased recently.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
NPCT Yearly Dividends per shareNPCT Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

132.14% of the earnings are spent on dividend by NPCT. This is not a sustainable payout ratio.
DP132.14%
EPS Next 2YN/A
EPS Next 3YN/A
NPCT Yearly Income VS Free CF VS DividendNPCT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2021 2022 2023 2024 0 50M -50M 100M -100M -150M
NPCT Dividend Payout.NPCT Dividend Payout, showing the Payout Ratio.NPCT Dividend Payout.PayoutRetained Earnings

More info and screens

NUVEEN CORE PLUS IMPACT

NYSE:NPCT (6/6/2025, 8:13:57 PM)

After market: 10.68 0 (0%)

10.68

-0.06 (-0.56%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners35.47%
Inst Owner Change-11.92%
Ins OwnersN/A
Ins Owner Change0%
Market Cap0
Analysts0
Price TargetN/A
Short Float %0.05%
Short Ratio0.07
Dividend
Industry RankSector Rank
Dividend Yield 12.27%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP132.14%
Div Incr Years1
Div Non Decr Years1
Ex-Date05-15 2025-05-15 (0.119)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 11.13
Fwd PE N/A
P/S 9.99
P/FCF 6.73
P/OCF 6.73
P/B 0.9
P/tB 0.9
EV/EBITDA N/A
EPS(TTM)0.96
EY8.99%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)1.59
FCFY14.85%
OCF(TTM)1.59
OCFY14.85%
SpS1.07
BVpS11.83
TBVpS11.83
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 5.21%
ROE 8.16%
ROCE 2.87%
ROIC 2.07%
ROICexc 2.07%
ROICexgc 2.08%
OM 45.29%
PM (TTM) 90.32%
GM 45.42%
FCFM 148.39%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-10.38%
OM growth 5YN/A
PM growth 3Y5.67%
PM growth 5YN/A
GM growth 3Y-8.8%
GM growth 5YN/A
F-Score7
Asset Turnover0.06
Health
Industry RankSector Rank
Debt/Equity 0.56
Debt/FCF 4.17
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 1.28
Cash Conversion N/A
Profit Quality 164.29%
Current Ratio 0.01
Quick Ratio 0.01
Altman-Z 0.5
F-Score7
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)35.21%
EPS 3Y36.2%
EPS 5YN/A
EPS Q2Q%-23.73%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)4.36%
Revenue growth 3Y29.57%
Revenue growth 5YN/A
Sales Q2Q%-3.82%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y26.83%
EBIT growth 3Y16.13%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-22.03%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-22.03%
OCF growth 3YN/A
OCF growth 5YN/A